Integrated Wealth Concepts’s Day One Biopharmaceuticals DAWN Stock Holding History

Integrated Wealth Concepts’s Portfolio DAWN Stock Details DAWN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-19,088	Closed	-$409K	–	2441
2026 Q1	$409K	Buy	+19,088	New	+$269K	﹤0.01%	1662
2025 Q4	–	Sell	-17,430	Closed	-$123K	–	1716
2025 Q3	$123K	Sell	17,430 -2,740	-14%	-$18.9K	﹤0.01%	1905
2025 Q2	$131K	Buy	20,170 +3,032	+18%	+$20.9K	﹤0.01%	1808
2025 Q1	$136K	Sell	17,138 -136	-0.8%	-$1.46K	﹤0.01%	1657
2024 Q4	$219K	Buy	+17,274	New	+$240K	﹤0.01%	1550

Other funds holding DAWN

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

Integrated Wealth Concepts's DAWN Position: Q2 2026 in Review

Integrated Wealth Concepts sold out of Day One Biopharmaceuticals (DAWN) in Q2 2026, closing a stake of 19,088 shares — an estimated $409K sold.

Integrated Wealth Concepts first reported a position in DAWN in Q4 2024 and held it in 5 quarters. The position peaked at $409K in Q1 2026. 1 fund tracked by Wall St. Rank holds DAWN as of Q2 2026.

Integrated Wealth Concepts reported no remaining Day One Biopharmaceuticals position as of Q2 2026 after selling out during the quarter.
Integrated Wealth Concepts sold 19,088 Day One Biopharmaceuticals shares in Q2 2026, an estimated $409K.
Integrated Wealth Concepts first reported a position in Day One Biopharmaceuticals in Q4 2024 and held it in 5 quarters.
Integrated Wealth Concepts's Day One Biopharmaceuticals position peaked at $409K in Q1 2026.
1 fund tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q2 2026.

Based on Integrated Wealth Concepts's 13F filing for Q2 2026, filed 12 Aug 2026.